Javascript must be enabled to continue!
Mucorales fungi suppress nitric oxide production by macrophages
View through CrossRef
ABSTRACT
Mucormycosis is classified by the National Institute of Allergy and Infectious Diseases as an emerging disease and is caused by
Mucorales
fungi. Despite the high morbidity and mortality rates associated with the disease, little is known about the host-pathogen interactions that dictate disease progression. The recent surge of mucormycosis cases among COVID-19 patients has thrust the disease and the lack of available treatments into the spotlight. Despite severe fungal angioinvasion and tissue necrosis during infection, clinical observations suggest a lack of pro-inflammatory responses. Understanding immune evasion mechanisms in mucormycosis can help guide potential therapeutic options. In this study, we demonstrate that
Mucorales
fungi can suppress the accumulation of nitric oxide (NO) in lipopolysaccharide- and interferon gamma-stimulated macrophages despite robust expression of the
Nos2
mRNA and inducible nitric oxide synthase protein. This suppressive activity requires fungal viability and direct contact with macrophages and is not due to restricted access to L-arginine substrate. While
Mucorales
fungi appear to be able to remove NO from its environment, it does not account for the full suppression that we observe and suggests that
Mucorales
employs at least two mechanisms. Future experiments will elucidate the mechanisms by which
Mucorales
fungi deplete NO accumulation by macrophages and the implications of this depletion in mucormycosis pathogenesis.
IMPORTANCE
In October 2022,
Mucorales
fungi were listed in the “High Priority Group” on the first-ever list of fungal priority pathogens by the World Health Organization. As the causative agent of mucormycosis,
Mucorales
have become of great clinical and public health importance with growing mucormycosis numbers, notably with the exponential rise of COVID-19-associated mucormycosis cases. Despite the dire need, there are limited therapeutic options to treat mucormycosis. Our research fills in critical gaps of knowledge about how
Mucorales
fungi evade the host immune system. Specifically, we offer evidence that
Mucorales
block nitric oxide production, which is a key mediator and signaling molecule of the mammalian innate immune response to microbial pathogens. Our work offers new insight into immune evasion mechanisms by
Mucorales
fungi.
Title: Mucorales
fungi suppress nitric oxide production by macrophages
Description:
ABSTRACT
Mucormycosis is classified by the National Institute of Allergy and Infectious Diseases as an emerging disease and is caused by
Mucorales
fungi.
Despite the high morbidity and mortality rates associated with the disease, little is known about the host-pathogen interactions that dictate disease progression.
The recent surge of mucormycosis cases among COVID-19 patients has thrust the disease and the lack of available treatments into the spotlight.
Despite severe fungal angioinvasion and tissue necrosis during infection, clinical observations suggest a lack of pro-inflammatory responses.
Understanding immune evasion mechanisms in mucormycosis can help guide potential therapeutic options.
In this study, we demonstrate that
Mucorales
fungi can suppress the accumulation of nitric oxide (NO) in lipopolysaccharide- and interferon gamma-stimulated macrophages despite robust expression of the
Nos2
mRNA and inducible nitric oxide synthase protein.
This suppressive activity requires fungal viability and direct contact with macrophages and is not due to restricted access to L-arginine substrate.
While
Mucorales
fungi appear to be able to remove NO from its environment, it does not account for the full suppression that we observe and suggests that
Mucorales
employs at least two mechanisms.
Future experiments will elucidate the mechanisms by which
Mucorales
fungi deplete NO accumulation by macrophages and the implications of this depletion in mucormycosis pathogenesis.
IMPORTANCE
In October 2022,
Mucorales
fungi were listed in the “High Priority Group” on the first-ever list of fungal priority pathogens by the World Health Organization.
As the causative agent of mucormycosis,
Mucorales
have become of great clinical and public health importance with growing mucormycosis numbers, notably with the exponential rise of COVID-19-associated mucormycosis cases.
Despite the dire need, there are limited therapeutic options to treat mucormycosis.
Our research fills in critical gaps of knowledge about how
Mucorales
fungi evade the host immune system.
Specifically, we offer evidence that
Mucorales
block nitric oxide production, which is a key mediator and signaling molecule of the mammalian innate immune response to microbial pathogens.
Our work offers new insight into immune evasion mechanisms by
Mucorales
fungi.
Related Results
Role of Fractional Exhaled Nitric Oxide for Monitoring Bronchial Asthma
Role of Fractional Exhaled Nitric Oxide for Monitoring Bronchial Asthma
Background: Monitoring during treatment of asthma is usually done by various clinical tools, spirometry, sputum eosinophils and fractional exhaled nitric oxide. Fractional exhaled ...
Inhibition of Platelet Aggregation by Inhaled Nitric Oxide in Patients with Acute Respiratory Distress Syndrome
Inhibition of Platelet Aggregation by Inhaled Nitric Oxide in Patients with Acute Respiratory Distress Syndrome
Background
Nitric oxide inhibits platelet adhesion and aggregation in vitro. The aim of this prospective study was to assess the platelet antiaggregating activity of ni...
A patatin‐like protein protects Toxoplasma gondii from degradation in activated macrophages
A patatin‐like protein protects Toxoplasma gondii from degradation in activated macrophages
SummaryThe apicomplexan parasite Toxoplasma gondii is able to suppress nitric oxide production in activated macrophages. A screen of over 6000 T. gondii insertional mutants identif...
CD14 is not involved in Rhodobacter sphaeroides diphosphoryl lipid A inhibition of tumor necrosis factor alpha and nitric oxide induction by taxol in murine macrophages
CD14 is not involved in Rhodobacter sphaeroides diphosphoryl lipid A inhibition of tumor necrosis factor alpha and nitric oxide induction by taxol in murine macrophages
Taxol, a microtubule stabilizer with anticancer activity, mimics the actions of lipopolysaccharide (LPS) on murine macrophages in vitro. Recently, it was shown that taxol-induced m...
INCREASED NITRIC OXIDE SYNTHESIS IN PERITONEAL MACROPHAGES UNDER THE ACTION OF ASCORBIC ACID
INCREASED NITRIC OXIDE SYNTHESIS IN PERITONEAL MACROPHAGES UNDER THE ACTION OF ASCORBIC ACID
The effect of ascorbic acid (AA) on the formation of nitric oxide (NO) in peritoneal macrophages of SHK line mice was studied. ESR and UV spectroscopy revealed a significant increa...
Sex Differences in the Abundance of Endothelial Nitric Oxide in a Model of Genetic Hypertension
Sex Differences in the Abundance of Endothelial Nitric Oxide in a Model of Genetic Hypertension
AbstractA deficiency of nitric oxide may be responsible for the increased vascular resistance associated with human essential hypertension and that seen in animal models of hyperte...
Abstract 1450: Tumor-associated glycans interact with macrophages through class-A scavenger receptor
Abstract 1450: Tumor-associated glycans interact with macrophages through class-A scavenger receptor
Abstract
Introduction. Tumor initiation and growth are associated with modifications to the glycan structure of glycoproteins, glycolipids and proteoglycans present ...
CD137-CD137L Signaling Affects Angiogenesis by Mediating Phenotypic Conversion of Macrophages
CD137-CD137L Signaling Affects Angiogenesis by Mediating Phenotypic Conversion of Macrophages
Background:
Angiogenesis in atherosclerotic plaque is an important factor causing plaque hemorrhage, vulnerability, and rupture, and different phenotypes of macrophages...

